Evidence map›Paper›PMID 37261234›Full record

ArticleFrontiers in public health2023

Whole-genome sequencing of multidrug resistance

Sareen Fatima, Zaara Ishaq, Muhammad Irfan, Abdullah F AlAsmari, Jahangir Khan Achakzai, Tahreem Zaheer, Amjad Ali, Ali Akbar

Abstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TheInfectious disorders drug targets · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sareen FatimaDepartment of Microbiology, University of Balochistan, Quetta, Balochistan, Pakistan.
Zaara IshaqAtta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology, (NUST), Islamabad, Pakistan.
Muhammad IrfanJamil-ur-Rahman Center for Genome Research, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan.
Abdullah F AlAsmariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Jahangir Khan AchakzaiDisipline of Biochemistry, Department of Natural and Basic Sciences, University of Turbat Kech, Balochistan, Pakistan.
Tahreem ZaheerDepartment of Biology, Indiana University Bloomington, Bloomington, IN, United States.
Amjad AliAtta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology, (NUST), Islamabad, Pakistan.
Ali AkbarDepartment of Microbiology, University of Balochistan, Quetta, Balochistan, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this study, Results and Discussion: MLST analysis showed that QS194, belonged to ST19, which is commonly associated with

Indexed as

Anti-Bacterial AgentsSalmonella typhiDrug Resistance, MultipleHumansMultilocus Sequence TypingPakistanVirulence FactorsWhole Genome SequencingAnti-Bacterial AgentsVirulence Factorsantibiotics resistancediseasesenteric infectionspathogenic bacteriasuperbugs

Identifiers

PMID37261234
PMCPMC10227597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.